anti-TNBC agent-2 structure
|
Common Name | anti-TNBC agent-2 | ||
|---|---|---|---|---|
| CAS Number | 2422001-22-5 | Molecular Weight | 542.09 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H37ClFN7O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of anti-TNBC agent-2anti-TNBC agent-2 an anti-Triple negative breast cancer (TNBC) purine derivative. anti-TNBC agent-2 induces MDA-MB-231 cells apoptosis, and inhibits its migration and angiogenesis. anti-TNBC agent-2 inhibits tumor growth and metastasis and reduces the expression of Ki67 and CD31 protein in TNBC xenograft models. anti-TNBC agent-2 can be used for Triple negative breast cancer (TNBC) research[1]. |
| Name | anti-TNBC agent-2 |
|---|
| Description | anti-TNBC agent-2 an anti-Triple negative breast cancer (TNBC) purine derivative. anti-TNBC agent-2 induces MDA-MB-231 cells apoptosis, and inhibits its migration and angiogenesis. anti-TNBC agent-2 inhibits tumor growth and metastasis and reduces the expression of Ki67 and CD31 protein in TNBC xenograft models. anti-TNBC agent-2 can be used for Triple negative breast cancer (TNBC) research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C28H37ClFN7O |
|---|---|
| Molecular Weight | 542.09 |
| InChIKey | LFXYFFIMEFNDHC-UHFFFAOYSA-N |
| SMILES | OCCN1CCC(C2CCN(c3nc(NCc4ccc(F)c(Cl)c4)c4ncn(CC5CC5)c4n3)CC2)CC1 |